582 related items for PubMed ID: 12931273
1. Plasma and salivary 6beta-hydroxycortisol measurements for assessing adrenocortical activity in patients with adrenocortical adenomas.
Varga I, Jakab C, Szücs N, Patócs A, Tóth M, Kiss R, Gláz E, Rácz K.
Horm Metab Res; 2003 Jul; 35(7):421-6. PubMed ID: 12931273
[Abstract] [Full Text] [Related]
2. Plasma 6beta-hydroxycortisol measurements for assessing altered hepatic drug metabolizing enzyme activity.
Szücs N, Varga I, Patócs A, Tóth M, Jakab C, Gláz E, Rácz K.
Acta Physiol Hung; 2003 Jul; 90(3):217-23. PubMed ID: 14594192
[Abstract] [Full Text] [Related]
3. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
Castro M, Elias LL, Elias PC, Moreira AC.
Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
[Abstract] [Full Text] [Related]
4. Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders.
Restituto P, Galofré JC, Gil MJ, Mugueta C, Santos S, Monreal JI, Varo N.
Clin Biochem; 2008 Jun; 41(9):688-92. PubMed ID: 18280810
[Abstract] [Full Text] [Related]
5. Secretion of 6beta-hydroxycortisol by normal human adrenals and adrenocortical adenomas.
Szucs N, Varga I, Patócs A, Tóth M, Gláz E, Rácz K.
Steroids; 2003 May; 68(5):477-82. PubMed ID: 12798499
[Abstract] [Full Text] [Related]
6. The dexamethasone suppression test and long-term contraceptive treatment: measurement of ACTH or salivary cortisol does not improve the reliability of the test.
Nickelsen T, Lissner W, Schöffling K.
Exp Clin Endocrinol; 1989 May; 94(3):275-80. PubMed ID: 2560985
[Abstract] [Full Text] [Related]
7. Characteristics of recovery of adrenocortical function after treatment for Cushing's syndrome due to pituitary or adrenal adenomas.
Klose M, Jørgensen K, Kristensen LØ.
Clin Endocrinol (Oxf); 2004 Sep; 61(3):394-9. PubMed ID: 15355458
[Abstract] [Full Text] [Related]
8. Ectopic Cortisol-producing Adrenocortical Adenoma Detected by 131I-6β-iodomethyl-norcholesterol Scintigraphy.
Sato S, Imachi H, Kobayashi T, Fukunaga K, Lyu J, Dong T, Yoshioka Y, Saheki T, Fukata Y, Ban N, Urushihara K, Kadota K, Murao K.
Intern Med; 2020 Jul 15; 59(14):1731-1734. PubMed ID: 32238722
[Abstract] [Full Text] [Related]
9. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
Tsagarakis S, Kokkoris P, Roboti C, Malagari C, Kaskarelis J, Vlassopoulou V, Alevizaki C, Thalassinos N.
Clin Endocrinol (Oxf); 1998 May 15; 48(5):627-33. PubMed ID: 9666875
[Abstract] [Full Text] [Related]
10. Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma.
Ermetici F, Malavazos AE, Corbetta S, Morricone L, Dall'Asta C, Corsi MM, Ambrosi B.
Metabolism; 2007 May 15; 56(5):686-92. PubMed ID: 17445545
[Abstract] [Full Text] [Related]
11. Positive rate-sensitive corticosteroid feedback mechanism of ACTH secretion in Cushing's disease.
Fehm HL, Voigt KH, Kummer G, Pfeiffer EF.
J Clin Invest; 1979 Jul 15; 64(1):102-8. PubMed ID: 221540
[Abstract] [Full Text] [Related]
12. Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion.
Tzanela M, Zianni D, Stylianidou Ch, Karavitaki N, Tsagarakis S, Thalassinos NC.
Clin Endocrinol (Oxf); 2005 May 15; 62(5):597-602. PubMed ID: 15853831
[Abstract] [Full Text] [Related]
13. Hyper-responsiveness of adrenal gland to vasopressin resulting in enhanced plasma cortisol in patients with adrenal nodule(s).
Suzuki S, Uchida D, Koide H, Tanaka T, Noguchi Y, Saito Y, Tatsuno I.
Peptides; 2008 Oct 15; 29(10):1767-72. PubMed ID: 18620013
[Abstract] [Full Text] [Related]
14. Basal and ACTH-stimulated cortisol and aldosterone release from adrenocortical adenomas in vitro.
Gröndal S, Grimelius L, Thorén M, Hamberger B.
Eur J Surg; 1991 Mar 15; 157(3):179-83. PubMed ID: 1678626
[Abstract] [Full Text] [Related]
15. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
Robaczyk MG.
Ann Acad Med Stetin; 2002 Mar 15; 48():283-300. PubMed ID: 14601484
[Abstract] [Full Text] [Related]
16. Increased ratio of mRNA expression of the genes CYP17 and CYP11B1 indicates autonomous cortisol production in adrenocortical tumors.
Enberg U, Hennings J, Volpe C, Hellman P, Höög A, Hamberger B, Thorén M.
J Endocrinol Invest; 2009 Nov 15; 32(10):810-5. PubMed ID: 19564722
[Abstract] [Full Text] [Related]
17. Correlation of alkaline phosphatase staining of cortisol-producing adrenocortical tumors with dexamethasone suppression and ACTH stimulation.
Aiba M.
Acta Pathol Jpn; 1977 Nov 15; 27(6):877-91. PubMed ID: 204155
[Abstract] [Full Text] [Related]
18. Cushing's syndrome due to bilateral adrenocortical adenomas with unique histological features.
Nomura K, Saito H, Aiba M, Iihara M, Obara T, Takano K.
Endocr J; 2003 Apr 15; 50(2):155-62. PubMed ID: 12803235
[Abstract] [Full Text] [Related]
19. Benign cortisol-secreting adrenocortical adenomas produce small amounts of androgens.
Kamenicky P, Houdoin L, Ferlicot S, Salenave S, Brailly S, Droupy S, Meduri G, Sasano H, Suzuki T, Young J, Chanson P.
Clin Endocrinol (Oxf); 2007 Jun 15; 66(6):778-88. PubMed ID: 17408424
[Abstract] [Full Text] [Related]
20. A new less-invasive and more informative low-dose ACTH test: salivary steroids in response to intramuscular corticotrophin.
Contreras LN, Arregger AL, Persi GG, Gonzalez NS, Cardoso EM.
Clin Endocrinol (Oxf); 2004 Dec 15; 61(6):675-82. PubMed ID: 15579180
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
